NCT06801106Completed
Acapella Versus Lung Flute in Treatment of COPD Patients the Study Aims to Identify the Preference Between the Two Devices According to Treatment of COPD Patients Regarding Pulmonary Function Tests , Exercise Tolerence and Quality of Life Questionnaire,
ACAPELLA VERSUS LUNG FLUTE in TREATMENT of CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: ClinicalTrials.gov · Last updated 30 Jan 2025
Brief summary (registry, in English)
Chronic obstructive pulmonary disease (COPD) is a prevalent and progressive condition characterized by persistent airflow limitation and chronic respiratory symptoms. Among the many approaches to managing COPD, airway clearance techniques (ACTs) play a pivotal role in improving pulmonary function, reducing symptoms, and enhancing quality of life. So, this study aimed to investigate the comparative efficacy of two ACT devices-the Acapella® and the Lung Flute®- on improving pulmonary function, exercise capacity, and quality of life in COPD patients. The Acapella® and the Lung Flute®. Both devices utilize distinct mechanisms to facilitate mucus clearance and improve lung function. The Acapella® combines positive expiratory pressure (PEP) with oscillatory vibration, aiding in the loosening and mobilization of mucus . On the other hand, the Lung Flute® generates low-frequency sound waves through patient exhalation, stimulating mucus movement from the peripheral to central airways . While both devices have demonstrated efficacy in previous studies, there is limited comparative research evaluating their impact in COPD patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 70 (actual)
- First submitted
- 24 Jan 2025
- Start date
- 31 Jan 2021
- Primary completion date
- 20 Jan 2024
- Lead sponsor
- Ministry of Health and Population, Egypt
- Diseases
- COPD
- NCT number
- NCT06801106
What you commit to
- Study type: Interventional
- Participants enrolled: 70
- From 31 Jan 2021 to the primary completion date, 20 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- • History of osteoporosis, significant gastro-esophageal reflux, hiatus hernia.
- Recent acute cardiac event (6 weeks) or congestive cardiac failure.
- Any significant musculoskeletal disorders.
- Presence of active hemoptysis.
- Presence of malignant disease.
- Patients undergoing exacerbations.
- Patients of hospital admission in last 6 month.
- Patients with cough, rhonchi, and expectoration in last 6 month.
- Patients who undergo exertional desaturation of oxygen below 90% after 6MWT.
- Patients who suffer from prolonged recovery time of HR for more than one minute after finishing 6MWT.
- Prolonged recovery time of heart rate \<1 min.
- Patients who cannot walk.
Who the study is looking for
- \- Moderate and mild severe COPD patients were selected according GOLD guidelines.
- All patients were diagnosed as COPD with chronic bronchitis for at least two years.
- All Patients were using their prescribed medications including Broncho-dilators and mucolytics.
- Patients ceased smoking 2 months before undergoing the study.
- Patients were selected of BMI between 25-34.9.
Age in the registry: 40 years to 60 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cairo University Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.